The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorderStephen V. Faraone, Diane Purper‐Ouakil, Yufeng Wang et al.|Neuroscience & Biobehavioral Reviews|2021Cited by 1.4k
Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for PsychopharmacologyBlanca Bolea-Alamañac, David Nutt, Marios Adamou et al.|Journal of Psychopharmacology|2014Cited by 284
Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Preterm Birth, and Small for Gestational AgeZixuan Wang, Kenneth K. C. Man, Adrienne Y L Chan et al.|JAMA Internal Medicine|2021Cited by 91
Attention-deficit/hyperactivity disorder medication consumption in 64 countries and regions from 2015 to 2019: a longitudinal studyAdrienne Y L Chan, Ian Chi Kei Wong, Tiantian Ma et al.|EClinicalMedicine|2023Cited by 70
Maternal Benzodiazepines and Z-Drugs Use during Pregnancy and Adverse Birth and Neurodevelopmental Outcomes in Offspring: A Population-Based Cohort StudyAdrienne Y L Chan, Kenneth K. C. Man, Le Gao et al.|Psychotherapy and Psychosomatics|2023Cited by 26